New rules applicable to Shanghai's Lin-Gang New Area have been released. Wenpei Yu and Yunsi Hu of Lifeng Partners analyze their workings, how they fit into China's existing system of cross-border data transfer rules and why they are so significant for biomedical companies operating in the zone
U.S. plans to restrict Chinese software in electric and internet-connected cars; China increases control over offshore capital flows; and Chinese firms plan to expand into the U.S. Midwest but have regulatory concerns.
WeRide IPO shows another green light for overseas listing of Chinese companies; China imposes new regulations for local authorities to better implement its state secrets law overhaul; and two Chinese state departments release new rules for QFII to stimulate foreign securities investment.
National standards are published on compliance audit requirements of the protection of personal information
Vehicles should allow one-touch halting of collection of out-of-vehicle data
Shanghai FTZ elaborates on the general data of the biomedical sector
Philip Qu and Qiuchen Wang from TransAsia Lawyers analyze a pioneering approach to regulating cross-border data transfers recently adopted in one of Shanghai's free trade zones
Shanghai FTZ elaborates on the general data of the public fund sector
Shanghai FTZ expedites cross-border transfer of specified data; CBP investigation finds no substantial evidence of evasion by CIE; and Another Chinese EV SPAC merger is in the pipeline but EU tariffs threaten the business.
Charles Wu of Clyde & Co describes the current regulatory state of China's investment market, for private equity investors, including the much anticipated recent clarity provided by key regulators as well as potential pitfalls to avoid
